Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Cataract Extraction: later-stage trial registry

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cataract Extraction: 5 US clinical trials tracked, none currently recruiting.

Cataract Extraction is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 2 of these trials.

Enrollment posture brief

Registry condition cataract-extraction

OPEN 0 | RECR 0% | LATE 3 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cataract Extraction (this)0%
Open-enrollment share among volume-matched conditions near Cataract Extraction

Cataract Extraction has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cataract Extraction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cataract Extraction is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cataract Extraction research.

    Medical University of South Carolina accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Cataract Extraction trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Cataract Extraction research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31Phase 42

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Cataract Extraction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Besifloxacin 0.6% ophthalmic suspension Drug
1 trials
Moxifloxacin 0.5% ophthalmic solution Drug
1 trials
aspheric ReSTOR multifocal intraocular lens (IOL) Device
1 trials
Cataract surgery and IOL implantation Device
1 trials
OMS302-PE Drug
1 trials
OMS302 Drug
1 trials
ketorolac Drug
1 trials
Vehicle Drug
1 trials

US sites by state

Facility locations filed on Cataract Extraction trials. A trial with sites in several states counts in each.

South Carolina 2 trials
California 2 trials
Wisconsin 1 trials
Missouri 1 trials
Minnesota 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cataract Extraction page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cataract Extraction condition card totals 5 registered trials; most-linked intervention Besifloxacin 0.6% ophthalmic suspension; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.